Myers Scott Dunseth
Insider CIK 1356256 · DVAX Director · CASC President and CEO, Director · SELB Director · VRDN Chief Executive Officer, Director · TRIL Director · HARP Director · ZNTL Director · AMAG President & CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZNTL Zentalis Pharmaceuticals, | A Award | 2026-06-16 | 2026-06-18 | 57,100 | — | $0 | 395,895 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 16,875 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 45,000 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 22,500 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 22,500 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 28,500 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer | 2026-02-10 | 2026-02-10 | 31,204 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | U Tender | 2026-02-10 | 2026-02-10 | 3,800 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | P Buy | 2025-08-22 | 2025-08-25 | 3,800 | $10.82 | $41.1K | 35,004 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2025-06-17 | 2025-06-18 | 57,603 | — | $0 | 338,795 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2025-06-11 | 2025-06-13 | 28,500 | — | $0 | 28,500 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2025-06-11 | 2025-06-13 | 5,758 | — | $0 | 31,204 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | P Buy | 2025-04-30 | 2025-04-30 | 21,000 | $1.40 | $29.4K | 281,192 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2024-11-13 | 2024-11-13 | 260,192 | — | $0 | 260,192 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2024-05-23 | 2024-05-28 | 22,500 | — | $0 | 22,500 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2024-05-23 | 2024-05-28 | 5,357 | — | $0 | 25,446 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 2,033 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 4,600 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer | 2024-03-11 | 2024-03-11 | 22,665 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2024-01-01 | 2024-01-03 | 2,048 | — | $0 | 22,666 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2023-11-27 | 2023-11-28 | 5,000 | — | $0 | 20,618 | SEC↗ |
| RNAC Cartesian Therapeutics, In | D To issuer deriv | 2023-11-13 | 2023-11-15 | 87,500 | $0.93 | $81.4K | 0 | SEC↗ |
| RNAC Cartesian Therapeutics, In | D To issuer deriv | 2023-11-13 | 2023-11-15 | 20,000 | — | $0 | 0 | SEC↗ |
| RNAC Cartesian Therapeutics, In | D To issuer deriv | 2023-11-13 | 2023-11-15 | 20,000 | — | $0 | 0 | SEC↗ |
| RNAC Cartesian Therapeutics, In | D To issuer deriv | 2023-11-13 | 2023-11-15 | 40,000 | — | $0 | 0 | SEC↗ |
| RNAC Cartesian Therapeutics, In | D To issuer deriv | 2023-11-13 | 2023-11-15 | 40,000 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2023-10-01 | 2023-10-02 | 5,797 | — | $0 | 15,618 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2023-07-01 | 2023-07-06 | 35,634 | — | $0 | 98,215 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 46,000 | — | $0 | 46,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2023-05-26 | 2023-05-31 | 22,500 | — | $0 | 22,500 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2023-05-26 | 2023-05-31 | 5,357 | — | $0 | 20,089 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | P Buy | 2023-04-12 | 2023-04-12 | 4,000 | $25.37 | $101.5K | 259,500 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2023-04-01 | 2023-04-04 | 34,925 | — | $0 | 62,581 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | P Buy | 2023-03-13 | 2023-03-13 | 5,500 | $29.15 | $160.3K | 255,500 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2023-02-06 | 2023-02-07 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award | 2023-02-06 | 2023-02-07 | 250,000 | — | $0 | 250,000 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | A Award deriv | 2023-01-02 | 2023-01-04 | 87,500 | — | $0 | 87,500 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 20,334 | — | $0 | 20,334 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2022-05-26 | 2022-05-27 | 4,018 | — | $0 | 4,018 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2022-05-26 | 2022-05-27 | 16,875 | — | $0 | 16,875 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | A Award deriv | 2022-01-03 | 2022-01-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 67,000 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2021-10-25 | 2021-10-26 | 10,167 | — | $0 | 10,167 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2021-10-19 | 2021-10-21 | 10,714 | — | $0 | 10,714 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2021-10-19 | 2021-10-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2021-05-04 | 2021-05-07 | 10,167 | — | $0 | 10,167 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2021-05-04 | 2021-05-14 | 10,167 | — | $0 | 10,167 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | A Award deriv | 2021-05-03 | 2021-05-05 | 67,000 | — | $0 | 67,000 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | A Award deriv | 2021-03-30 | 2021-04-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | D To issuer deriv | 2020-11-16 | 2020-11-17 | 1,000,000 | — | $0 | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | A Award deriv | 2020-06-19 | 2020-06-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2020-05-28 | 2020-06-01 | 10,167 | — | $0 | 10,167 | SEC↗ |
| AMAG AMAG PHARMACEUTICALS, INC. | A Award deriv | 2020-04-28 | 2020-04-30 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | A Award deriv | 2019-12-23 | 2019-12-26 | 19,704 | $0.13 | $2.6K | 19,704 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | A Award | 2019-12-23 | 2019-12-26 | 39,409 | $1.46 | $57.5K | 80,845 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | A Award | 2019-08-20 | 2019-08-20 | 41,436 | $1.81 | $75.0K | 41,436 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | A Award deriv | 2019-06-14 | 2019-06-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2019-06-03 | 2019-06-05 | 10,167 | — | $0 | 10,167 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 42,000 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 6,300 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 15,500 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 250,000 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 60,000 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 190,000 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 474,810 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | U Tender | 2018-03-09 | 2018-03-13 | 56,787 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2018-02-01 | 2018-02-02 | 250,000 | — | $0 | 250,000 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise deriv | 2018-01-11 | 2018-01-16 | 10,500 | — | $0 | 31,500 | SEC↗ |
| CASC Cascadian Therapeutics, In | F Tax w/h | 2018-01-11 | 2018-01-16 | 3,429 | $3.92 | $13.4K | 56,787 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise | 2018-01-11 | 2018-01-16 | 10,500 | — | $0 | 60,216 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2017-11-10 | 2017-11-13 | 6,300 | — | $0 | 6,300 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2017-09-18 | 2017-09-20 | 15,500 | — | $0 | 15,500 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2017-09-18 | 2017-09-20 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CASC Cascadian Therapeutics, In | P Buy | 2017-08-11 | 2017-08-14 | 5,500 | $3.74 | $20.6K | 49,716 | SEC↗ |
| CASC Cascadian Therapeutics, In | P Buy | 2017-05-12 | 2017-05-16 | 2,800 | $4.00 | $11.2K | 44,216 | SEC↗ |
| CASC Cascadian Therapeutics, In | P Buy | 2017-03-31 | 2017-04-04 | 2,000 | $4.11 | $8.2K | 41,416 | SEC↗ |
| CASC Cascadian Therapeutics, In | P Buy | 2017-03-20 | 2017-03-21 | 1,000 | $3.93 | $3.9K | 39,416 | SEC↗ |
| CASC Cascadian Therapeutics, In | P Buy | 2017-01-27 | 2017-01-31 | 20,500 | $3.76 | $77.1K | 38,416 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2017-01-11 | 2017-01-13 | 190,000 | — | $0 | 190,000 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2017-01-11 | 2017-01-13 | 42,000 | — | $0 | 42,000 | SEC↗ |
| CASC Cascadian Therapeutics, In | P Buy | 2016-08-17 | 2016-08-18 | 45,000 | $1.15 | $51.7K | 107,500 | SEC↗ |
| CASC Cascadian Therapeutics, In | P Buy | 2016-06-28 | 2016-06-28 | 62,500 | $0.80 | $50.0K | 62,500 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2016-04-04 | 2016-04-06 | 2,848,855 | — | $0 | 2,848,855 | SEC↗ |